| The genetic landscape of high-risk neuroblastoma TJ Pugh, O Morozova, EF Attiyeh, S Asgharzadeh, JS Wei, D Auclair, ... Nature genetics 45 (3), 279-284, 2013 | 1263 | 2013 |
| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 590 | 2015 |
| Comparison of RNA-seq and microarray-based models for clinical endpoint prediction W Zhang, Y Yu, F Hertwig, J Thierry-Mieg, W Zhang, D Thierry-Mieg, ... Genome biology 16, 1-12, 2015 | 428 | 2015 |
| Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy KB Challagundla, PM Wise, P Neviani, H Chava, M Murtadha, T Xu, ... Journal of the National Cancer Institute 107 (7), djv135, 2015 | 391 | 2015 |
| Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages L Song, S Asgharzadeh, J Salo, K Engell, H Wu, R Sposto, T Ara, ... The Journal of clinical investigation 119 (6), 1524-1536, 2009 | 364 | 2009 |
| Common variations in BARD1 influence susceptibility to high-risk neuroblastoma M Capasso, M Devoto, C Hou, S Asgharzadeh, JT Glessner, EF Attiyeh, ... Nature genetics 41 (6), 718-723, 2009 | 353 | 2009 |
| Chromosome 6p22 locus associated with clinically aggressive neuroblastoma JM Maris, YP Mosse, JP Bradfield, C Hou, S Monni, RH Scott, ... New England Journal of Medicine 358 (24), 2585-2593, 2008 | 329 | 2008 |
| Revised neuroblastoma risk classification system: a report from the Children's Oncology Group MS Irwin, A Naranjo, FF Zhang, SL Cohn, WB London, JM Gastier-Foster, ... Journal of Clinical Oncology 39 (29), 3229-3241, 2021 | 321 | 2021 |
| Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma S Asgharzadeh, JA Salo, L Ji, A Oberthuer, M Fischer, F Berthold, ... Journal of Clinical Oncology 30 (28), 3525-3532, 2012 | 307 | 2012 |
| Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2 LS Metelitsa, HW Wu, H Wang, Y Yang, Z Warsi, S Asgharzadeh, ... The Journal of experimental medicine 199 (9), 1213-1221, 2004 | 296 | 2004 |
| Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification S Asgharzadeh, R Pique-Regi, R Sposto, H Wang, Y Yang, H Shimada, ... Journal of the National Cancer Institute 98 (17), 1193-1203, 2006 | 259 | 2006 |
| NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome M Hölzel, S Huang, J Koster, I Øra, A Lakeman, H Caron, W Nijkamp, ... Cell 142 (2), 218-229, 2010 | 233 | 2010 |
| Cancer-associated fibroblasts share characteristics and protumorigenic activity with mesenchymal stromal cells L Borriello, R Nakata, MA Sheard, GE Fernandez, R Sposto, J Malvar, ... Cancer research 77 (18), 5142-5157, 2017 | 174 | 2017 |
| CASC15-S is a tumor suppressor lncRNA at the 6p22 neuroblastoma susceptibility locus MR Russell, A Penikis, DA Oldridge, JR Alvarez-Dominguez, L McDaniel, ... Cancer research 75 (15), 3155-3166, 2015 | 167 | 2015 |
| Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous … SL Gardner, S Asgharzadeh, A Green, B Horn, G McCowage, J Finlay Pediatric blood & cancer 51 (2), 235-240, 2008 | 167 | 2008 |
| Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed … J Fangusaro, J Finlay, R Sposto, L Ji, M Saly, S Zacharoulis, ... Pediatric blood & cancer 50 (2), 312-318, 2008 | 165 | 2008 |
| Sparse representation and Bayesian detection of genome copy number alterations from microarray data R Pique-Regi, J Monso-Varona, A Ortega, RC Seeger, TJ Triche, ... Bioinformatics 24 (3), 309-318, 2008 | 164 | 2008 |
| Irinotecan, temozolomide, and dinutuximab with GM-CSF in children with refractory or relapsed neuroblastoma: a report from the Children’s Oncology Group R Mody, AL Yu, A Naranjo, FF Zhang, WB London, BL Shulkin, MT Parisi, ... Journal of Clinical Oncology 38 (19), 2160-2169, 2020 | 162 | 2020 |
| IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity D Liu, L Song, J Wei, AN Courtney, X Gao, E Marinova, L Guo, A Heczey, ... The Journal of clinical investigation 122 (6), 2221-2233, 2012 | 159 | 2012 |
| ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome S Huang, J Laoukili, MT Epping, J Koster, M Hölzel, BA Westerman, ... Cancer cell 15 (4), 328-340, 2009 | 157 | 2009 |
